{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:16:28Z","timestamp":1761718588926},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejpb.2017.06.012","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T13:30:35Z","timestamp":1497360635000},"page":"107-113","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Forecasting gastrointestinal precipitation and oral pharmacokinetics of dantrolene in dogs using an in vitro precipitation testing coupled with in silico modeling and simulation"],"prefix":"10.1016","volume":"119","author":[{"given":"Atsushi","family":"Kambayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer B.","family":"Dressman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2017.06.012_b0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejps.2016.06.006","article-title":"Use of physiologically relevant biopharmaceutics tools within the pharmaceutical industry and in regulatory sciences: Where are we now and what are the gaps?","volume":"91","author":"Flanagan","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.06.012_b0010","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/acs.molpharmaceut.5b00861","article-title":"In silico modeling of gastrointestinal drug absorption: predictive performance of three physiologically based absorption models","volume":"13","author":"Sjogren","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0015","article-title":"IMI - oral biopharmaceutics tools project - evaluation of bottom-up PBPK prediction success part 1: Characterisation of the OrBiTo database of compounds","author":"Margolskee","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.06.012_b0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejps.2013.09.008","article-title":"PBPK models for the prediction of in vivo performance of oral dosage forms","volume":"57C","author":"Kostewicz","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.06.012_b0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejpb.2014.01.007","article-title":"Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium","volume":"87","author":"Kambayashi","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0030","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/jphp.12059","article-title":"Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage forms","volume":"65","author":"Otsuka","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2017.06.012_b0035","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.ejpb.2013.09.009","article-title":"Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac","volume":"85","author":"Kambayashi","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2010.05.009","article-title":"Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans","volume":"76","author":"Shono","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2016.03.020","article-title":"Prediction of the precipitation profiles of weak base drugs in the small intestine using a simplified transfer (\u201cdumping\u201d) model coupled with in silico modeling and simulation approach","volume":"103","author":"Kambayashi","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejps.2013.12.004","article-title":"Evaluation of the use of classical nucleation theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs","volume":"53","author":"Carlert","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.06.012_b0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1021\/acs.molpharmaceut.5b00808","article-title":"Development of a unified dissolution and precipitation model and its use for the prediction of oral drug absorption","volume":"13","author":"Jakubiak","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejpb.2016.04.004","article-title":"Characterizing the dissolution profiles of supersaturable salts, cocrystals, and solvates to enhance in vivo oral absorption","volume":"103","author":"Hisada","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2012.12.001","article-title":"An in vitro-in silico-in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: case example dantrolene","volume":"84","author":"Kambayashi","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jphp.12320","article-title":"Identification of key factors affecting the oral absorption of salts of lipophilic weak acids: a case example","volume":"67","author":"Petrakis","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2017.06.012_b0075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0080","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.06.012_b0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2013.01.010","article-title":"Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state","volume":"84","author":"Arndt","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1773-2247(06)50089-9","article-title":"Effect of gastric acidity regulation on the gastrointestinal transit time and secretion of gastric fluids in beagle dogs","volume":"16","author":"Mori","year":"2006","journal-title":"J. Drug. Deliv. Sci. Tec."},{"key":"10.1016\/j.ejpb.2017.06.012_b0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vascn.2011.04.008","article-title":"Using pharmacokinetic modeling to determine the effect of drug and food on gastrointestinal transit in dogs","volume":"64","author":"Sjodin","year":"2011","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejpb.2017.06.012_b0100","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s11095-008-9637-9","article-title":"Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation","volume":"25","author":"Takano","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.06.012_b0105","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1021\/mp300104s","article-title":"A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability","volume":"9","author":"Miller","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejpb.2017.06.012_b0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/j.1552-4604.1996.tb04153.x","article-title":"Metoclopramide increases the bioavailability of dantrolene in spinal cord injury","volume":"36","author":"Gilman","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2017.06.012_b0120","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/jps.24541","article-title":"Amorphous solid dispersions: utilization and challenges in drug discovery and development","volume":"104","author":"He","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.06.012_b0125","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1021\/mp400465p","article-title":"In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs","volume":"11","author":"Higashino","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.012_b0130","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jbiomech.2006.06.006","article-title":"A stomach road or \u201cMagenstrasse\u201d for gastric emptying","volume":"40","author":"Pal","year":"2007","journal-title":"J. Biomech."},{"key":"10.1016\/j.ejpb.2017.06.012_b0135","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/mp500022u","article-title":"Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI","volume":"11","author":"Koziolek","year":"2014","journal-title":"Mol. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117305180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117305180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T07:34:06Z","timestamp":1537169646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117305180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":27,"alternative-id":["S0939641117305180"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.06.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Forecasting gastrointestinal precipitation and oral pharmacokinetics of dantrolene in dogs using an in vitro precipitation testing coupled with in silico modeling and simulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}